Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Germ Cell and Embryonal × Erlotinib Hydrochloride × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Pancreatic Neoplasms 2 Lung Neoplasms 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Papillary renal cell carcinoma, sporadic 1 Pancreatic Intraductal Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Hereditary leiomyomatosis and renal cell cancer 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Adult Solid Neoplasm 1

Interventions

fludarabine 3 Cyclophosphamide 3 fludarabine phosphate 2 Sirolimus 2 Etoposide 2 Cisplatin 2 Carboplatin 2 tremelimumab 1 pralsetinib 1 pembrolizumab 1 etoposide phosphate 1 durvalumab 1 cabozantinib 1 Surveys and Questionnaires 1 Stem Cell Transplantation 1 Standard of Care 1 Specimen Handling 1 Respiratory Physiological Phenomena 1 Proton Therapy 1 Practice Guidelines as Topic 1 Platinum 1 Pemetrexed 1 Paclitaxel 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Celecoxib 1 Busulfan 1 Bleomycin 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡